Osr Holdings Inc (OSRH) Stock Price, Quote & News

Company Profile

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is...

Industry: Biotechnology

Sector: Healthcare

Phone: 425 635 7700

Website: www.osr-holdings.com

Address:

10900 NE 4th Street, Suite 2300, Bellevue, United States

paulc19802 May. 15 at 10:36 PM

$OSRH unless I've missed something there is NOT a public offering happening. They have to announce them they can't just randomly dilute the stock by selling onto the open market. Any dilution occuring can only be from giving shares to insiders. It's not from selling unless those insider's are just instantly selling their stock. Unless anyone can correct me and provide a source pointing to a filed public offering announcement?

1 · Reply

jeffthechef May. 15 at 10:30 PM

@ACInvestorBlog check out $OSRH over the weekend! Double your money at least in short term. imo Just signed a 815 million dollar deal. Plus they are able to sell 50,000 for $10 each within 6 months. 🚀 Plus just announced no reverse split will be needed. They at .57 now. Shows real conviction that they will get it over a dollar before August, which is just around the corner.

0 · Reply

urgetosurge May. 15 at 10:27 PM

$OSRH the overhang here is a possible rs. While not mentioned, the proxy keeps any and all issues to be open. The outstanding increase isn't helping but imo that's the overhang. Just my take https://www.otcmarkets.com/filing/html?id=19428938&guid=iJj-kKMYSjQBV3h

1 · Reply

JoNCherry May. 15 at 9:35 PM

$OSRH seems they will release the news on money received via ATM once dilution done

1 · Reply

KeepItRealistic May. 15 at 8:53 PM

$OSRH company likes putting big news pre Market See you all on Monday

0 · Reply

Roland115 May. 15 at 8:39 PM

$OSRH I wish this company to reach over a dollar and more... I made a lot of money here on several entries... on the other hand, I was very surprised that even with a volume of 300 million, it didn't even come close..... he probably threw out new shares in the process...

0 · Reply

KeepItRealistic May. 15 at 8:36 PM

$OSRH fliptards gone Mega rewards for those holding

0 · Reply

ItsMeMario707 May. 15 at 8:29 PM

$OSRH It’s starting to get tight and it looks like there’s not enough buyers defending. With no catalyst or rumor of any good news in the coming week I imagine we will see a break of the current wedge downward. I’m thinking low $.50s for sure. I don’t think low $.50s support will break since there’s plenty of people willing to buy there but the longer it goes without breaking out of $.70 the higher the probability reverse split gets put back on the table.

0 · Reply

Roland115 May. 15 at 8:16 PM

$OSRH God, this is a trader 🤣 He keeps writing the same thing 😁 I wonder if he ever takes a profit or watches how the profit slips through his fingers every time 😁 they don't want to let you go above 0.70... finally understand that this is played in the long term from the lower limit where you buy... my buying zone is 0.40-0.45... the current buying zone is currently set at 0.50-0.53... everything is sold from 0.60-0.70...✅ When there is good news, it warms up above 0.70 for a while...✅ look at the annual structure of the chart...✅

0 · Reply

hitlist0 May. 15 at 8:03 PM

$OSRH clear dilution going on hoping this stays .55c

1 · Reply

OSR Holdings CEO says company not pursuing reverse stock split

May 12, 2026, 9:16 AM EDT - 3 days ago

CEO Statement to Shareholders

May 5, 2026, 1:05 PM EDT - 10 days ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Reaffirms Buy-Emerging Rating and $10.00 Price Target

Apr 30, 2026, 9:15 AM EDT - 15 days ago

OSR Holdings to Present VXM01 Licensing Agreement at Emerging Growth Conference May 7, 2026

2026-04-29T16:28:46.000Z - 16 days ago

OSR Holdings enters $815M global license agreement for VXM01 with BCM Europe

Apr 29, 2026, 9:50 AM EDT - 16 days ago

OSR Holdings Executes Definitive $815 Million Global License Agreement for VXM01 with BCM Europe

2026-04-09T13:34:34.000Z - 5 weeks ago

OSR Holdings eliminates $2.02M warrant overhang

Apr 9, 2026, 9:15 AM EDT - 5 weeks ago

OSR Holdings Eliminates $2.02 Million Warrant Overhang with Premium-Priced Convertible Note

Mar 30, 2026, 9:00 AM EDT - 6 weeks ago

OSR Holdings to Update Investors at the Emerging Growth Conference on April 1, 2026

Mar 27, 2026, 9:00 AM EDT - 7 weeks ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target

2026-03-23T12:46:05.000Z - 7 weeks ago

OSR Holdings announces update to $815M VXM01 licensing deal structure

Mar 23, 2026, 8:30 AM EDT - 7 weeks ago

OSR Holdings Updates $815 Million VXM01 Licensing Deal Structure to Capture Value at Parent Level

2026-03-19T13:07:19.000Z - 2 months ago

OSR Holdings subsidiary signs NDA with Sinopharm

2026-03-19T13:07:07.000Z - 2 months ago

OSR Holdings subsidiary signs NDA with Sinopharm

Mar 19, 2026, 8:55 AM EDT - 2 months ago

Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities

2026-03-05T14:44:08.000Z - 2 months ago

OSR Holdings granted 180-day Nasdaq extension

Mar 5, 2026, 9:30 AM EST - 2 months ago

OSR Holdings, Inc. Granted 180-Day Nasdaq Extension; Reaffirms Strategic Momentum

2026-02-02T14:55:28.000Z - 3 months ago

OSR Holdings CEO says fundamentals of business ‘remain strong’

2026-01-27T13:50:45.000Z - 3 months ago

OSR Holdings completes Woori IO acquisition

Jan 27, 2026, 8:30 AM EST - 3 months ago

OSR Holdings Completes Woori IO Acquisition, Secures Long-Term Shareholder Alignment, and Reviews Strategic Combination of Medical Device Subsidiaries

Jan 22, 2026, 9:55 AM EST - 4 months ago

Woori IO, an OSR Company, Highlights FDA Clarification on Non-Medical Wearables as a Catalyst for Accelerated Commercial Launch

Jan 16, 2026, 9:20 AM EST - 4 months ago

Vaximm Appoints Sébastien Wieckowski, PhD, as Chief Scientific Officer to Advance Next-Generation Oral Immunotherapy Platform

Jan 12, 2026, 8:05 AM EST - 4 months ago

Vaximm, an OSR Company, Receives Binding Term Sheet from BCM Europe for Global Exclusive License of VXM01 with $30M Upfront and Up to $815M in Milestones

2025-12-19T16:55:10.000Z - 5 months ago

OSR Holdings announces Woori IO shareholders approve share exchange

Dec 19, 2025, 11:50 AM EST - 5 months ago

Woori IO Shareholders Approve Share Exchange to Become Wholly-Owned Subsidiary of OSR Holdings

Dec 4, 2025, 3:19 PM EST - 5 months ago

Emerging Growth Research Issues Flash Report on OSR Holdings, Inc., Reaffirms Buy-Emerging Rating and $10.00 Price Target Following Major Licensing Agreement

2025-12-02T15:06:23.000Z - 5 months ago

Vaximm updates term sheet with BCM Europe to shorten exclusivity period

Dec 2, 2025, 9:53 AM EST - 5 months ago

Vaximm AG, an OSR Company, Updates Term Sheet with BCM Europe to Shorten Exclusivity Period to Three Months

Dec 1, 2025, 3:01 PM EST - 5 months ago

OSR Holdings to Present at the Emerging Growth Conference on December 10, 2025

2025-11-21T14:25:17.000Z - 6 months ago

OSR Holdings’ Vaximm AG enters non-binding term sheet with BCM Europe

Nov 21, 2025, 9:20 AM EST - 6 months ago

Vaximm AG, an OSR Company, Enters Term Sheet With BCM Europe for Potential VXM01 License with $20M Upfront and Up to $815M in Milestones

Nov 14, 2025, 11:10 AM EST - 6 months ago

OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion

2025-11-06T13:48:10.000Z - 6 months ago

OSR Holdings’ glucose monitor demonstrates accuracy and precision in pilot study

Nov 6, 2025, 8:30 AM EST - 6 months ago

OSR Holdings Announces Woori IO's Noninvasive Glucose Monitor Demonstrates High Accuracy and Precision in Company-Sponsored Pilot Study

Oct 20, 2025, 11:39 AM EDT - 7 months ago

Emerging Growth Research Initiates Coverage on OSR Holdings, Inc. with a Buy-Emerging Rating and $10.00 Price Target

2025-10-14T12:41:26.000Z - 7 months ago

OSR Holdings to acquire Woori IO for needle-free glucose monitoring

Oct 14, 2025, 8:30 AM EDT - 7 months ago

OSR Holdings Signs Definitive Agreement to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring with Potential to Transform Diabetes Care

2025-09-09T21:35:11.000Z - 8 months ago

OSR Holdings receives non-compliance letter from Nasdaq

Sep 9, 2025, 5:30 PM EDT - 8 months ago

OSR Holdings Receives Nasdaq Minimum Bid Price Deficiency Notice; Company Highlights Unusual Trading Activity

Aug 1, 2025, 1:29 PM EDT - 10 months ago

OSR Holdings to Host Virtual Investor Event Providing Key Corporate Updates and Strategic Direction on August 6, 2025

Jul 31, 2025, 12:45 PM EDT - 10 months ago

OSR Holdings Provides Transparency Update on Equity Financing Instruments

Jul 30, 2025, 4:10 PM EDT - 10 months ago

OSR Holdings Provides Strategic Update on Woori IO Term Sheet and Share Exchange Structure

2025-07-24T11:41:06.000Z - 10 months ago

OSR Holdings to acquire glucose monitoring provider Woori IO

Jul 24, 2025, 7:30 AM EDT - 10 months ago

OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology

Jul 15, 2025, 7:30 AM EDT - 10 months ago

OSR Holdings Appoints Dr. Andreas Niethammer as Chief Medical Officer of Vaximm AG, an OSR Company

2025-07-09T12:05:08.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

Jul 9, 2025, 7:58 AM EDT - 11 months ago

OSR Holdings Announces Strategic Roadmap for Tokenization Under Reg D Framework in Partnership with BCM Europe AG

2025-07-08T14:16:29.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

2025-07-08T14:10:12.000Z - 11 months ago

OSR Holdings announces strategic roadmap for tokenization

2025-05-28T21:30:31.000Z - 1 year ago

OSR Holdings files to sell 15.41M shares of common stock for holders

May 22, 2025, 7:36 AM EDT - 1 year ago

OSR Holdings, BCM Europe, and Taekwondo Cooperative Announce Strategic MOU to Launch Blockchain-Based OSRH Token

May 2, 2025, 7:30 AM EDT - 1 year ago

Darnatein to Present at 14th International BMP Conference Highlighting Advances in Regenerative Biologics

Apr 9, 2025, 7:54 AM EDT - 1 year ago

Darnatein, an OSR Company, Broadens Intellectual Property Protection for Innovative Osteoarthritis Treatment Technology

Apr 3, 2025, 7:30 AM EDT - 1 year ago

OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM's Non-Profit Ecosystem to Accelerate Glioblastoma Therapies

Mar 26, 2025, 7:16 AM EDT - 1 year ago

Vaximm AG, an OSR Company, Announces Results from Phase 2a Trial of VXM01 and Avelumab Combination Therapy in Glioblastoma

Mar 25, 2025, 7:00 AM EDT - 1 year ago

OSR Holdings Appoints Dr. Constance Höfer as Chief Scientific Officer

Feb 14, 2025, 6:10 PM EST - 1 year ago

OSR Holdings, Inc. and OSR Holdings Co., Ltd. Announce Completion of Business Combination

paulc19802 May. 15 at 10:36 PM

1 · Reply

jeffthechef May. 15 at 10:30 PM

0 · Reply

urgetosurge May. 15 at 10:27 PM

1 · Reply

JoNCherry May. 15 at 9:35 PM

$OSRH seems they will release the news on money received via ATM once dilution done

1 · Reply

KeepItRealistic May. 15 at 8:53 PM

$OSRH company likes putting big news pre Market See you all on Monday

0 · Reply

Roland115 May. 15 at 8:39 PM

0 · Reply

KeepItRealistic May. 15 at 8:36 PM

$OSRH fliptards gone Mega rewards for those holding

0 · Reply

ItsMeMario707 May. 15 at 8:29 PM

0 · Reply

Roland115 May. 15 at 8:16 PM

0 · Reply

hitlist0 May. 15 at 8:03 PM

$OSRH clear dilution going on hoping this stays .55c

1 · Reply

KeepItRealistic May. 15 at 7:31 PM

$OSRH monkey at .575 needs to lose his shares

1 · Reply

uptrend2025 May. 15 at 7:26 PM

$OSRH Drop news AH and be like 🚀 🧨

1 · Reply

Angdsz May. 15 at 7:16 PM

$OSRH

2 · Reply

lukchard420 May. 15 at 6:36 PM

$OSRH bullish pennant... soon to breakout

1 · Reply

Angdsz May. 15 at 6:16 PM

$OSRH Triangle

0 · Reply

IldijanaMM May. 15 at 6:16 PM

$OSRH Patience and no brainer!

2 · Reply

KeepItRealistic May. 15 at 6:07 PM

$OSRH .57x’s were nice while they lasted Dumb money moving over to smart money

0 · Reply

IldijanaMM May. 15 at 5:47 PM

$OSRH 14% volume of a avg day in volume. It’s Friday and shorts is taking advantage to help whales. Loaded some more and I would like to thank you if you sold to me. 🎯 10$ I can spear 20 cent

0 · Reply

patientboy May. 15 at 4:57 PM

$OSRH added 1450 shares more loading zone don’t miss this opportunity 🔥✈️

0 · Reply

Panda0820 May. 15 at 4:25 PM

$OSRH Market is Red today so relax 😌 and have a beer

0 · Reply

KeepItRealistic May. 15 at 4:09 PM

$OSRH it’s coming 👇 just under 2 months have passed since NDA signing … “In parallel, Woori IO continues to advance its non-invasive glucose monitoring platform through its collaboration with Samsung Electronics, while also progressing discussions under NDA with Sinopharm.” Woori IO, an OSR Company, Signs NDA with Sinopharm to Explore China Commercial Opportunities OSR Holdings, Inc. March 19, 2026 https://ca.finance.yahoo.com/news/woori-io-osr-company-signs-125500772.html

0 · Reply

Panda0820 May. 15 at 4:08 PM

$OSRH Going to close Green

0 · Reply

Market Cap	21.65M
Revenue (ttm)	2.91M
Net Income (ttm)	-27.06M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-929.90%
Debt to Equity Ratio	0.03

Volume	1,156,800
Avg Vol	7,776,348
Day's Range	N/A - N/A
Shares Out	35.11M
Stochastic %K	41%
Beta	0.86
Analysts	Strong Buy
Price Target	N/A